METEORIC-HF: Omecamtiv mecarbil fails to improve exercise performance in HFrEF - Healio

WASHINGTON — In well-treated patients with chronic HF with reduced ejection fraction, omecamtiv mecarbil did not improve measures of exercise capacity over 20 weeks compared with placebo, researchers reported. Exercise is a “cardinal manifestation…

Source/Disclosures Source: Felker GM, et al. Joint American College of Cardiology/New England Journal of Medicine Late-Breaking Clinical Trials. Presented at: American College of Cardiology Scienti… [+7566 chars]

full article...